Tacke, MD, PhD, U., Uosukainen, MSci (Pharm), H., Kananen, BSci (Pharm), M., Kontra, Pharm Lic, K. and Pentikäinen, MD, H. 2018. A pilot study about the feasibility and cost-effectiveness of electronic compliance monitoring in substitution treatment with buprenorphine—naloxone combination. Journal of Opioid Management. 5, 6 (Jan. 2018), 321–329. DOI:https://doi.org/10.5055/jom.2009.0032.